Article info
Hepatology
Original research
Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling
- Correspondence to Dr Kai-Chien Yang, Graduate Institute and Department of Pharmacology, National Taiwan University College of Medicine, Taipei, Taiwan; kcyang{at}ntu.edu.tw
Citation
Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling
Publication history
- Received May 2, 2021
- Accepted December 5, 2021
- First published December 21, 2021.
Online issue publication
August 11, 2022
Article Versions
- Previous version (21 December 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.